The Danish version of the medication adherence report scale: Preliminary validation in cancer pain patients

Pain Practice

Volumn 9, Issue 1, 2009, Pages 1-7

  Jacobsen, Ramune ^a,b   Møldrup, Claus ^a   Christrup, Lona ^a   Sjøgren, Per ^c   Hansen, Ole Bo ^d  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b FKL Research Centre for Quality in Medicine Use

^c Rigshospitalet

^d HOLBÆK HOSPITAL   (Denmark)

Author keywords

Cancer pain management; Psychometric properties; Questionnaire; Self reported adherence

Indexed keywords

ANALGESIC AGENT;

ADULT; ARTICLE; CANCER PAIN; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DANISH VERSION OF THE MEDICATION ADHERENCE REPORT SCALE; DISEASE SEVERITY; DOCTOR PATIENT RELATION; HEALTH CARE QUALITY; HUMAN; INTERPERSONAL COMMUNICATION; PAIN ASSESSMENT; PAIN THRESHOLD; PATIENT COMPLIANCE; PSYCHOMETRY; RELIABILITY; SCORING SYSTEM; SELF REPORT; TREATMENT RESPONSE; VALIDATION PROCESS; VALIDITY;

ANALGESICS; COMMUNICATION; HUMANS; MEDICATION ADHERENCE; NEOPLASMS; PAIN; PAIN MEASUREMENT; PHYSICIAN-PATIENT RELATIONS; QUESTIONNAIRES;

EID: 58249140730     PISSN: 15307085     EISSN: 15332500     Source Type: Journal    
DOI: 10.1111/j.1533-2500.2008.00245.x     Document Type: Article

References (50)

1. Cherny NI. The assessment of cancer pain. In: McMillan SC, Koltzenburg M, eds. Wall and Melzack's Textbook of Pain. 5th ed. Churchill Livingstone: Elsevier; 2006:1099-1125.
2. Grond S, Radbruch L, Meuser T, et al. Assessment and treatment of neuropathic cancer pain following WHO Guidelines. Pain. 1999;79:15-20.
3. Meuser T, Pietruck C, Radbruch L, et al. Symptoms during cancer pain treatment following WHO-guidelines: A longitudinal follow-up study of symptom prevalence, severity and etiology. Pain. 2001;93:247-257.
4. Syrjala KO, Cleeland CS. How to assess cancer pain. In: Turk DC, Melzack R, eds. Handbook of Pain Assessment. 2nd ed. New York: The Guilford Press; 2001:579-600.
5. Zech DF, Grond S, Lynch J, Hertel D, Lehmann KA. Validation of World Health Organization Guidelines for cancer pain relief: A 10-year prospective study. Pain. 1995;63:65-76.
6. Schug SA, Gandham N. Opioids: Clinical use. In: McMillan SC, Koltzenburg M, eds. Wall and Melzack's Textbook of Pain. 5th ed. Churchill Livingstone: Elsevier; 2006:443-457.
7. Redmond K. Organizational barriers in opioid use. Support Care Cancer. 1997;5:451-456.
8. Jacobsen R, Sjogren P, Moldrup C, Christrup L. Physician-related barriers to cancer pain management with opioid analgesics: A systematic review. J Opioid Manag. 2007;3:207-214.
9. Pargeon KL, Hailey BJ. Barriers to effective cancer pain management: A review of the literature. J Pain Symptom Manag. 1999;18:358-368.
10. Cleeland CS. Barriers to the management of cancer pain. Oncology (Williston Park). 1987;1:19-26.
11. Lai YH, Keefe FJ, Sun WZ, et al. Relationship between pain-specific beliefs and adherence to analgesic regimens in Taiwanese cancer patients: A preliminary study. J Pain Symptom Manag. 2002;24:415-423.
12. Schumacher KL, West C, Dodd M, et al. Pain management autobiographies and reluctance to use opioids for cancer pain management. Cancer Nurs. 2002;25:125-133.
13. Tzeng JI, Chang CC, Chang HJ, Lin CC. Assessing analgesic regimen adherence with the morisky medication adherence measure for Taiwanese patients with cancer pain. J Pain Symptom Manag. 2008;36:157-166.
14. Garber MC, Nau DP, Erickson SR, Aikens JE, Lawrence JB. The concordance of self-report with other measures of medication adherence: A summary of the literature. Med Care. 2004;42:649-652.
15. Anderson KO, Richman SP, Hurley J, et al. Cancer pain management among underserved minority outpatients-perceived needs and barriers to optimal control. Cancer. 2002;94:2295-2304.
16. Ediger JP, Walker JR, Graff L, et al. Predictors of medication adherence in inflammatory bowel disease. Am J Gastroenterol. 2007;102:1417-1426.
17. Farmer A, Wade A, French DP, et al. The DiGEM trial protocol - a randomised controlled trial to determine the effect on glycaemic control of different strategies of blood glucose self-monitoring in people with type 2 diabetes [ISRCTN47464659]. BMC Fam Pract. 2005;6:25.
18. George J, Kong DCM, Thoman E, Stewart K. Factors associated with medication nonadherence in patients with COPD. Chest. 2005;128:3198-3204.
19. Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999;47:555-567.
20. Menckeberg TT, Bouvy ML, Bracke M, et al. Beliefs about medicines predict refill adherence to inhaled corticosteroids. J Psychosom Res. 2008;64:47-54.
21. O'Caroll RE, McGregor LM, Swanson V, Masterton G, Hayes PC. Adherence to medication after liver transplantation in scotland: A pilot study. Liver Transpl. 2006;12:1862-1868.
22. Haynes RB, Taylor DW, Sackett DL, et al. Can simple clinical measurements detect patient noncompliance? Hypertension. 1980;2:757-764.
23. Kravitz RL, Hays RD, Sherbourne CD, et al. Recall of recommendations and adherence to advice among patients with chronic medical conditions. Arch Intern Med. 1993;153:1869-1878.
24. Horne R, Hankins M, Jenkins R. The Satisfaction with Information about Medicines Scale (SIMS): A new measurement tool for audit and research. Qual Health Care. 2001;10:135-140.
25. Schumacher KL, Koresawa S, West C, et al. Putting cancer pain management regimens into practice at home. J Pain Symptom Manag. 2002;23:369-382.
26. Cull A, Sprangers M, Bjordal K, Aaronson N, West K, Bottomley A. EORTC quality of life group translation procedure. Brussels: EORTC. 2002.
27. Gunnarsdottir S, Donovan HS, Serlin RC, Voge C, Ward S. Patient-related barriers to pain management: The barriers questionnaire II (BQ-II). Pain. 2002;99:385-396.
28. Smith MY, Winkel G, Egert J, az-Wionczek M, DuHamel KN. Patient-physician communication in the context of persistent pain: validation of a modified version of the patients' Perceived Involvement in Care Scale. J Pain Symptom Manag. 2006;32:71-81.
29. Cleeland CS, Syrjala KO. How to assess cancer pain. In: Turk DC, Melzack R, eds. Handbook of Pain Assessment. New York: Guildford Press; 1992;362-390.
30. Cleeland CS, Ryan KM. Pain assessment: Global use of the Brief Pain Inventory. Ann Acad Med Singapore. 1994;23:129-138.
31. Klepstad P, Loge JH, Borchgrevink PC, et al. The Norwegian brief pain inventory questionnaire: Translation and validation in cancer pain patients. J Pain Symptom Manag. 2002;24: 517-525.
32. Fayers PM, Machin D. Quality of Life. Assessment, Analysis and Interpretation. Chichester: John Wiley & Sons Ltd; 2007.
33. Stevens JP. Applied Multivariate Statistics for the Social Sciences. Mahwah, NJ: Lawrence Erlbaum Associates Publishers, 2002.
34. Kilner T. Educating the ambulance technician, paramedic, and clinical supervisor: Using factor analysis to inform the curriculum. Em Med J. 2004;21:379-385.
35. Altman DG. Practical Statistics for Medical Research. London: Chapman & Hall/CRC; 1991.
36. Rudd P. The measurement of compliance: Medication taking. In: Krasnegor NA, Epstein LH, Johnson SB, Yaffe SJ, eds. Developmental Aspects of Health Compliance Behavior. Hillsdale, NJ: Lawrence Erlbaum; 1993:185-213.
37. Butler JA, Peveler RC, Roderick P, et al. Modifiable risk factors for non-adherence to immunosuppressants in renal transplant recipients: A cross-sectional study. Nephrol Dial Transplant. 2004;19:3144-3149.
38. Byrne M, Walsh J, Murphy AW. Secondary prevention of coronary heart disease: Patient beliefs and health-related behaviour. J Psychosom Res. 2005;58:403-415.
39. Clatworthy J, Bowskill R, Rank T, Parham R, Horne R. Adherence to medication in bipolar disorder: A qualitative study exploring the role of patients' beliefs about the condition and its treatment. Bipolar Disorders. 2007;9:656-664.
40. Clifford S, Barber N, Elliott R, Hartley E, Horne R. Patient-centred advice is effective in improving adherence to medicines. Pharm World Sci. 2006;28:165-170.
41. Clifford S, Barber N, Horne R. Understanding different beliefs held by adherers, unintentional nonadherers, and intentional nonadherers: application of the Necessity-Concerns Framework. J Psychosom Res. 2008;64:41-46.
42. Gonzalez JS, Penedo FJ, Llabre MM, et al. Physical symptoms, beliefs about medications, negative mood, and long-term HIV medication adherence. Ann Behav Med. 2007;34:46-55.
43. Horne R, Clatworthy J, Polmear A, Weinman J. Do hypertensive patients' beliefs about their illness and treatment influence medication adherence and quality of life? J Hum Hypertens. 2001;15(suppl 1):S65-S68.
44. Karamanidou C, Weinman J, Horne R. Improving haemodialysis patients' understanding of phosphate-binding medication: A pilot study of a psycho-educational intervention designed to change patients' perceptions of the problem and treatment. Br J Health Psychol. 2008;13:205-214.
45. Karamanidou C, Clatworthy J, Weinman J, Horne R. A systematic review of the prevalence and determinants of nonadherence to phosphate binding medication in patients with end-stage renal disease. BMC Nephrol. 2008;9:2.
46. Peters KF, Horne R, Kong F, Francomano CA, Biesecker BB. Living with Marfan syndrome II. Medication adherence and physical activity modification. Clin Genet. 2001;60:283-292.
47. Ersek M, Kraybill BM, Du Pen A. Factors hindering patients' use of medications for cancer pain. Cancer Pract. 1999;7:226-232.
48. Potter VT, Wiseman CE, Dunn SM, Boyle FM. Patient barriers to optimal cancer pain control. Psychooncology. 2003;12:153-160.
49. Yun YH, Heo DS, Lee IG, et al. Multicenter study of pain and its management in patients with advanced cancer in Korea. J Pain Symptom Manag. 2003;25:430-437.
50. Babbie E. The Practice of Social Research. Belmont, CA: A Division of Wadsworth, Inc.; 1991.